These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12467187)

  • 21. Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents.
    O'Dell CM; Forke CM; Polaneczky MM; Sondheimer SJ; Slap GB
    Obstet Gynecol; 1998 Apr; 91(4):609-14. PubMed ID: 9540951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adolescent satisfaction with postpartum contraception and body weight concerns.
    Hellerstedt WL; Story M
    J Adolesc Health; 1998 Jun; 22(6):446-52. PubMed ID: 9627814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased 1-year continuation of DMPA among women randomized to self-administration: results from a randomized controlled trial at Planned Parenthood.
    Kohn JE; Simons HR; Della Badia L; Draper E; Morfesis J; Talmont E; Beasley A; McDonald M; Westhoff CL
    Contraception; 2018 Mar; 97(3):198-204. PubMed ID: 29246818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial.
    Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Dal Santo L; Ngwira B
    Lancet Glob Health; 2018 May; 6(5):e568-e578. PubMed ID: 29526707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with provision of depot medroxyprogesterone acetate to adolescents by US health care providers.
    Ermias Y; Morgan IA; Curtis KM; Whiteman MK; Horton LG; Zapata LB
    Contraception; 2019 May; 99(5):300-305. PubMed ID: 30763582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy.
    Lewis LN; Doherty DA; Hickey M; Skinner SR
    Contraception; 2010 May; 81(5):421-6. PubMed ID: 20399949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depo Provera: a profile of current users.
    Jarman H; Kovacs GT; Westcott M
    Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant reduction of repeat teen pregnancy in a comprehensive young parent program.
    Omar HA; Fowler A; McClanahan KK
    J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):283-7. PubMed ID: 18794024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depo Now: preventing unintended pregnancies among adolescents and young adults.
    Rickert VI; Tiezzi L; Lipshutz J; León J; Vaughan RD; Westhoff C
    J Adolesc Health; 2007 Jan; 40(1):22-8. PubMed ID: 17185202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting continuation rates of DMPA.
    Hubacher D; Goco N; Gonzalez B; Taylor D
    Contraception; 1999 Dec; 60(6):345-51. PubMed ID: 10715369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health Care Provider Attitudes and Practices Related to 'Quick Start' Provision of Combined Hormonal Contraception and Depot Medroxyprogesterone Acetate to Adolescents.
    Morgan IA; Ermias Y; Zapata LB; Curtis KM; Whiteman MK
    J Adolesc Health; 2019 Feb; 64(2):211-218. PubMed ID: 30392865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescent use of the monthly contraceptive injection.
    Tuchman LK; Huppert JS; Huang B; Slap GB
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):255-60. PubMed ID: 16171729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
    Nelson AL
    J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of depot medroxyprogesterone acetate in Thai adolescents.
    Chotnopparatpattara P; Taneepanichskul S
    Contraception; 2000 Sep; 62(3):137-40. PubMed ID: 11124361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of long-acting contraceptives in adolescents.
    Harel Z; Cromer B
    Pediatr Clin North Am; 1999 Aug; 46(4):719-32. PubMed ID: 10494253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.